Showing results (731-740 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|May 11, 2020
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro culturesKenrie P Y Hui, Man-Chun Cheung, Ranawaka A P M Perera, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatmentMolebogeng X Rangaka, Mike Frick, Gavin Churchyard, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trialAlexander Supady, Enya Weber, Marina Rieder, et al.
The Lancet. Respiratory Medicine|June 12, 2020
Immunomodulation by macrolides: therapeutic potential for critical careTom D Y Reijnders, Anno Saris, Marcus J Schultz, et al.
The Lancet. Respiratory Medicine|November 15, 2025
Effects of intraoperative higher versus lower positive end-expiratory pressure during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, randomised, controlled, phase 3 trial, , , et al.
The Lancet. Respiratory Medicine|November 2, 2025
Climate change and tuberculosis: an analytical frameworkMatthew J Saunders, Delia Boccia, Palwasha Y Khan, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
The Lancet. Respiratory Medicine|August 23, 2021
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trialStephan Ehrmann, Jie Li, Miguel Ibarra-Estrada, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trialMiriam J Johnson, Bronwen Williams, Catriona Keerie, et al.
Pageof 104